August 2005: Application from National Starch Food Innovation to approve phosphated distarch phosphate as a novel food ingredient. Status: Authorised.
Phosphated distarch phosphate is a modified resistant starch. It is derived from high amylose maize starch and contains a minimum of 70% dietary fibre. It is currently used as a food additive (E1413) as a freeze-thaw-stable thickener (stabilises the consistency of the foodstuff when frozen and thawed) within the European Union in products such as soups, sauces, frozen gravies and pie fillings.
The applicant proposed to market its phosphated distarch phosphate as a source of dietary fibre for use as a novel food ingredient in a range of low moisture food products, including biscuits, cakes, muffins, crackers, pasta, pizza dough, bread, ready-to-eat breakfast cereals, tortillas, bread products made with white flour and pretzels, at levels up to 35%. Approval was sought under Novel Foods Regulation (EC) No 258/97.
Before a novel food can be marketed legally in EU it requires a pre-market safety assessment under the Novel Food Regulation (EU) 2015/2283, previously 258/97 (EC). This is the Regulation establishes the legal basis for novel foods and the process for submitting a novel food authorisation(s).
One of the major changes under the revised Regulation, was the centralisation of the authorisation process at the EU level. Prior to this, applications for new novel foods were underwent initial assessment in a Member State to achieve an EU wide authorisation. This application was received by the UK under Regulation 258/97 EC and was assessed by our independent experts the Advisory Committee on novel foods and processes.
Application Status: Authorised
The application for phospahted distrach phosphate was assessed by the UK under Regulation 258/97 (EC). On 23 August 2005 the company National Starch Food Innovation made a request to the UK for the assessment of phosphated distarch phosphate. The application was accepted and was reviewed by the Committee to assess it whether the proposed use met the requirements under the regulation. Namely that it is safe, not misleading and would not put consumers as a nutritional disadvantage.
The Committee completed its assessment and published its positive opinion. This opinion was shared with the other Member States resulting in the product being authorised by the EU subject to the conditions specified in the authorisation. The product was authorised under Commission Implementing Deicison (2011/494/EU).